CS Paper Radar

When uncertainty quantification fails: structural vulnerabilities and corrections for selective prediction under clinical class imbalance

Walter Endrizzi, Flavio Ragni, Raffaele Marchesi, Stefano Bovo, Monica Moroni, Giuseppe Jurman, Venet Osmani

cs.LG cs.AI ·submitted 2026-10-27 17:08 UTC · v1
code/data

Abstract

Background. Selective prediction systems improve the safety of clinical artificial intelligence by deferring ambiguous cases to human experts while automating high-confidence decisions. However, this safety mechanism relies entirely on the premise that uncertainty scores accurately reflect clinical ambiguity. In prognostic tasks characterized by severe class imbalance, where the clinical outcome of interest is a minority, this assumption breaks down. Standard uncertainty measures cease to capture clinically aligned ambiguity; instead, they become a proxy for class membership, systematically penalizing minority patients regardless of their individual predictive clarity. Results. Across 56 synthetic conditions and three neurodegenerative cohorts spanning severe class imbalance to near-balanced conditions (multiple sclerosis, Parkinson's Disease, Alzheimer's Disease), our framework consistently maintained bounded, balanced risk across trajectories. In contrast, global metrics either collapsed minority Sensitivity or protected the minority at the expense of majority patients. Applying CCR with standard entropy fails to protect the minority because it breaks within-class monotonicity when tau=0.5. Combining CCR with threshold-aware metrics restores strict monotonicity, correctly identifies ambiguous patients, and safely mitigates minority exclusion. Conclusions. Under clinical class imbalance, standard uncertainty quantification measures dataset sparsity rather than clinical ambiguity, creating a systemic illusion of safety. This bias is a correctable structural flaw. Clinical pipelines deploying selective prediction under imbalance should adopt threshold-aligned uncertainty measures and class-stratified evaluation. This reduces class-specific risk imbalance, supporting safer selective prediction under the evaluated conditions without silently excluding the most vulnerable patients.

Comment
https://github.com/endrwalter/uncertainty_ml

Closest papers

Nearest neighbours by meaning across the whole index.

Stochastic Grouping Conformal Prediction for Effective Subgroup Reliability

cs.LG cs.AI ·2026-10-08 ·Meihui Zhong, Wenxin Tai, Ting Zhong, Fan Zhou
theory similarity 0.65
Abstract · 9 pages

Conformal prediction offers a distribution-free coverage guarantee, making it especially attractive for clinical applications. Standard conformal prediction, however, provides such guarantees only at the population level, and its prediction sets can exhibit coverage disparities across clinically important subgroups. A natural remedy is to calibrate within predefined groups. However, this can require access to sensitive subgroup attributes and is prone to a worst-group bottleneck: protecting the most difficult subgroup can inflate prediction sets for all, increasing cognitive burden on decision makers. To this end, we propose Stochastic Grouping Conformal Prediction (SGCP), a conformal framework for subgroup-reliable uncertainty quantification. It learns a stochastic grouping map that allows each sample to draw calibration information from others with similar calibration behavior, yielding a local score law that boosts reliability across subpopulations. We prove that SGCP retains the standard coverage guarantee. Experiments on synthetic and real-world benchmarks show that it consistently reduces subgroup coverage gaps while achieving smaller or comparable prediction set sizes relative to existing baselines.

0.18

Beyond Uncertainty Reduction: Calibrated Planning for Interactive Diagnosis

cs.AI ·2026-08-28 ·Yue Zhou, Haiyang Zhou, Jin Zhang, Kong Wang, Zihao Rao +3 more
code/data similarity 0.62
Abstract

Interactive medical diagnosis requires an agent to gather patient evidence through sequential questions before committing to a diagnosis. Large language models (LLMs) now make such consultations feasible, and existing approaches typically select questions by how much they reduce uncertainty among candidate diseases. However, this objective is insensitive to the unequal clinical costs of diagnostic errors and omitted severe alternatives, so minimizing uncertainty need not minimize final diagnostic loss. To bridge this gap, we propose CaRDI (Calibrated Risk for Diagnostic Interaction), a planning framework built around a clinical loss combining primary diagnosis error with severity-weighted differential omission. Diagnostic and safety beliefs estimate the two loss components, while conformal residual calibration corrects for underestimation from partial evidence. The calibrated risk then guides question selection and stopping by balancing expected risk reduction against interaction cost. Experiments on multiple medical benchmarks show that CaRDI improves accuracy while requiring fewer questions. Further analysis shows that replacing entropy with clinical risk as the planning objective reduces clinical loss by 21.5% and decreases severe omissions. Our code is available at https://anonymous.4open.science/r/CaRDI-A940/.

0.28

FairGlucose: A CGM Fairness Benchmark Reveals Subgroup Disparities Hidden in Population-Level Validation

cs.CY cs.AI ·2026-08-18 ·Junjie Luo, Xuzhe Zhi, Rui Han, Abhimanyu Kumbara, Anand K. Iyer +3 more
benchmark similarity 0.61
Abstract

As CGM-based AI tools approach clinical deployment, whether their accuracy is equitable across patient demographics remains insufficiently tested. To enable this evaluation, we constructed FairGlucose, a 300-patient CGM cohort balanced across 12 demographic strata (age x gender x type 1/type 2 diabetes), with 132,480 forecasting samples and 3,945 unique behavioral events (meals, exercise, medication) logged by 81 patients. Benchmarking 33 models across four families on 2-hour glucose forecasting, we find that population-level external validation can conceal substantial subgroup disparities. Aggregate out-of-distribution metrics appear stable (approximately 1.0), yet subgroup-level ratios range from 0.8 to 1.4, with T1D patients showing 6 mg/dL higher prediction error than T2D (p < 0.001). This disparity persists across all 33 models, suggesting a property of the prediction task rather than any single architecture. Further analysis shows that subgroup performance gaps align with the proportion of clinically hard cases, and that input-length sensitivity varies across demographics, motivating personalized configurations. Frontier LLMs underperform specialized neural models by 1-6 mg/dL; behavioral events contribute negligibly (approximately 0.1 mg/dL) even under oracle event access. These findings establish that population-level validation alone is insufficient for equity assessment of digital health AI, motivating subgroup-disaggregated reporting as a default standard.

0.29

Beyond Demographic Balance: Multi-Metric and Intersectional Evaluation of Fairness in MIMIC-IV Mortality Prediction

cs.LG ·2026-10-01 ·Abdullah Al Noman, Fahmid Al Rifat, Tahrima Hashem, Syed Muhammad Ibne Zulfiker, Rishov Paul +1 more
similarity 0.61
Abstract · NEurlPS TAE workshop 2026 accepted

Fairness conclusions in clinical prediction can depend strongly on both the metrics reported and the demographic resolution at which performance is evaluated. We revisit these evaluation choices for ICU mortality prediction on MIMIC-IV, comparing predictive-utility and subgroup-error metrics across several fairness interventions. As a complementary case study, we introduce a lightweight adaptation strategy that jointly balances ethnicity--gender--insurance representation without conditioning on mortality outcomes, allowing demographic representation balancing to be examined separately from outcome-conditioned or direct error-rate interventions. We evaluate its behavior at both marginal and corresponding three-way intersectional subgroup levels, while accounting for the statistical support of finer-grained estimates. The results show that interventions can receive substantially different assessments across accuracy/AUROC, sensitivity, and false-positive rate, and that marginal demographic summaries can conceal heterogeneous error profiles within their constituent intersections, including among larger subgroups. These findings highlight the importance of evaluating fairness interventions at both complementary metric and subgroup resolutions, while accounting for the intervention target and the reliability of subgroup estimates.

0.15

The Ceiling Is in the Channel: Auditing Learner Gaps and Measurement Frontiers in Clinical Prediction

cs.AI ·2026-09-01 ·Sayeed Shafayet Chowdhury, Nusrat Jahan, Snehasis Mukhopadhyay, Shiaofen Fang, Vijay R. Ramakrishnan
similarity 0.61
Abstract

Clinical prediction can saturate for two different reasons: a fitted learner may fail to extract available information, or the recorded variables may impose a population frontier. We separate these quantities through the \emph{learner gap} and the \emph{measurement-channel ceiling}. Optimal balanced accuracy is characterized by total-variation separation, yielding architecture invariance, a sharp partial-identification result under replacement contamination, a cross-fitted ceiling estimator, and exact conditions for multimodal decision improvement. We add two finite-sample diagnostics, namely a label-permutation optimism floor and an underfit curve, and validate the audit on three real cohorts: UCI readmission ($n=99{,}343$), BRFSS diabetes ($n=253{,}680$), and NHANES HbA1c ($n=10{,}219$). Well-tuned gradient boosting nearly reaches the estimated frontier in UCI and BRFSS, whereas deliberately or practically deficient learners retain large gaps. NHANES yields a null difference between questionnaire and measured marginal frontiers but a significant joint complementarity gain, refining the simplistic claim that an objective modality must dominate. Across all cohorts, modest AUROC gains coexist with substantially larger Bayes decision-flip rates, and several architectures estimate similar frontiers while their achieved balanced accuracy differs sharply. A PRISMA-guided synthesis of 104 clinical tasks then shows that the same channel-level regularities recur across more than 18 disease categories: a broad but non-universal structured-clinical region, diminishing same-channel gains across model families, and higher performance when measurement channels change. The framework converts saturation from an empirical observation into an auditable decision: improve the learner when headroom remains; improve measurement when it does not.

0.18

Adaptive Conformal Redistribution for Inter-class Transitional Uncertainty in Medical Image Classification

cs.CV cs.AIcs.LGstat.CO+1 ·2026-09-10 ·Saibal Ghosh, Samarup Bhattacharya, Sanjoy Kumar Saha, Umapada Pal, Tapabrata Chakraborti
benchmarkcode/data similarity 0.61
Abstract

Medical image classification is frequently complicated by transitional categories whose feature distributions overlap those of adjacent classes, producing ambiguous decision boundaries. Conformal prediction returns uncertainty-aware prediction sets, but these are not directly actionable in clinical screening, where a single decision is required. This work proposes adaptive conformal redistribution (AdaConRed), a label-free post-conformal decision rule that converts ambiguous prediction sets into refined class assignments. A five-stage pipeline is developed. Vision-language generative augmentation addresses minority-class scarcity; a frozen DermFoundation encoder provides embeddings; a lightweight multi-layer perceptron performs classification; an entropy-modulated, margin-aware nonconformity score constructs adaptive prediction sets; samples predicted as transitional with multi-label sets are reassigned to the most probable alternative class within the set, using only model outputs at inference. Evaluation uses the OSCC oral lesion and ISIC skin lesion benchmarks at a miscoverage level of 0.2. On the 3-class OSCC benchmark, overall accuracy improves from 73.54% to 77.38%, with oral cancer accuracy rising from 64.29% to 82.14% and benign accuracy from 56.57% to 70.20%. Reassignment of transitional samples reduces OPMD accuracy from 84.78% to 80.16%, consistent with the asymmetric cost of missed malignancy. On ISIC, overall accuracy improves from 85.83% to 87.19%, melanoma accuracy rising from 66.04% to 68.34%. AdaConRed outperforms LAC, APS and RAPS under an identical backbone and redistribution rule. Conformal prediction can be extended beyond uncertainty quantification toward actionable decision support where transitional disease categories are present, with gains concentrated in the clinically critical malignant categories. Code repository: https://github.com/saibal436ghosh/AdaConRed.

0.38

Accuracy Is Not Risk: Why Medical AI Should Not Report Only Its Most Likely Label

cs.CY stat.MEcs.LGstat.AP ·2026-10-31 ·Jeffrey Humpherys, Makoto Jones
similarity 0.61
Abstract

Background. Many medical AI models are trained to reproduce a single reference label and hand the most likely label to the next step in a clinical workflow. A classifier can select that label correctly while providing an inadequate summary for estimating downstream risk. Methods. We use Jeffrey's rule of conditioning to specify when probabilities over intermediate states, such as diagnoses or imaging categories, can be carried forward to an outcome risk. We separate two errors of reporting only the most likely label, discarding the probability of the other states and applying the risk of patients who have the leading diagnosis to a patient who only probably has it. We also give conditions under which the label and the full distribution lead to the same decision, and we propose guardrails for device developers, regulatory reviewers, and health insurers. Results. In a hypothetical chest-pain differential, reporting only the benign leading diagnosis greatly understates the patient's risk of death or cardiac arrest, so a patient who warrants evaluation could be discharged or denied imaging. In a hypothetical BI-RADS example, the most likely category is "probably benign," yet the propagated malignancy risk exceeds the ceiling that defines that category. Conclusions. A predicted label is not an observed state, and a calibrated classifier is not automatically a valid outcome model. Clinical and insurance coverage decisions should rest on the patient's outcome risk, judged against a threshold justified by the consequences of acting and not acting. Developers should state what each model output means and check that every step between the model and the decision preserves the patient's risk.

0.07

Diagnosing Low-Confidence Patient Profiles via Localized Harmful Covariate Shift Detection

cs.LG cs.AI ·2026-10-13 ·Olivier Lefebvre, Hakima Laribi, Dan Poenaru, Martin Vallières
publishedcode/data similarity 0.61
Abstract · Accepted at SMASH (Symposium on Machine Learning and Applications in Healthcare) 2026. Code available at https://github.com/MEDomicsLab/stud…

Before deploying clinical prediction models, their reliability must be assessed to ensure safe use. Errors may arise from distribution shifts between training and deployment or from heterogeneous performance where the model systematically underperforms for certain patient subgroups. Yet most post-hoc diagnostic methods evaluate reliability only at the population level, checking whether the deployment data resemble the training data and whether the model performs well on average, without accounting for heterogeneity that may cause some patients to be disproportionately affected. We propose a unified diagnostic pipeline that combines both perspectives. MED3pa first discovers interpretable low-confidence patient profiles, and Detectron is then applied within each profile to test whether its degradation is associated with a detectable harmful covariate shift. Across three clinical prediction tasks and three injected subgroup shifts in MIMIC-IV, we find that shift detectability itself is informative. An injected age shift, undetectable at the population level, was nonetheless localized to specific degraded profiles, whereas sex- and race-related shifts were detected broadly and therefore offered little guidance for identifying the most affected patients.

0.47